Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
J Gastroenterol Hepatol
; 32(1): 199-207, 2017 Jan.
Article
in En
| MEDLINE
| ID: mdl-27194671
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Doxorubicin
/
Biomarkers, Tumor
/
Chemoembolization, Therapeutic
/
Carcinoma, Hepatocellular
/
MicroRNAs
/
Liver Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Gastroenterol Hepatol
Journal subject:
GASTROENTEROLOGIA
Year:
2017
Type:
Article
Affiliation country:
South Korea